| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |